CROSS-IMMUNOGENICITY OF VARIOUS BACTERIAL L-ASPARAGINASES


Cite item

Full Text

Abstract

Aim. Evaluate immune response in mice against various L-asparaginases and determine their cross-immunogenicity. Materials and methods. The studies were carried out in C 57Bl 6j line mice. Immunogenicity of L-asparaginases was studied: Escherichia coli type II (recombinant) (Medak, Germany) (ЕсА); Erwinia carotovora type II (ErA); Yersinia pseudotuberculosis type II (YpA); Rhodospirillum rubrum type I (RrA); Wollinella succinogenes type II (WsA). Immune response against the administered antigens was determined in EIA. Results. Y. pseudotuberculosis L-asparaginase was the most immunogenic, E. coli - the least immunogenic. E. carotovora, R. rubrum, W. succinogenes asparaginases displayed intermediate immunogenicity. The results of cross-immunogenicity evaluation have established, that blood sera of mice, that had received YpA, showed cross-immunogenicity against all the other L-asparaginase preparations except E. carotovora. During immunization with E. coli L-asparaginase the developed antibodies also bound preparation from E. carotovora. Sera from mice immunized with W. succinogenes, E. carotovora and R. rubrum L-asparaginases had cross-reaction only with EcA and did not react with other preparations. Conclusion. Cross-immunogenicity of the studied L-asparaginases was determined. A sequence of administration of the studied preparation is proposed that allows to minimize L-asparaginase neutralization by cross-reacting antibodies.

About the authors

I. N Dyakov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

V. S Pokrovsky

Blokhin Russian Oncologic Scientific Centre, Moscow, Russia

E. P Sannikova

State Research Institute of Genetics, Moscow, Russia

N. V Bulushova

State Research Institute of Genetics, Moscow, Russia

M. V Pokrovskaya

Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia

S. S Aleksandrova

Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia

References

  1. Соколов Н.Н., Эльдаров М.А., Сидорук К.В. и др. Разработка противоопухолевого препарата рекомбинантной L-аспарагиназы Erwinia carotovora. Молекулярная медицина. 2005, 1: 45-53.
  2. Abuchowski A., Kazo G.M., Verhoest C.R. Jr. et al. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys. 1984, 7 (2): 175-186.
  3. Asselin B.L., Whitin J.C., Coppola D.J. et al. Comparative pharmacokinetic studies ofthree asparaginase preparations. J. Clin. Oncol. 1993, 11: 1780-1786.
  4. Gaspar M.M., Perez-Soler R., Cruz M.E. Biological characterization of L-asparaginase liposomal formulations. Cancer Chemother. Pharmacol. 1996, 38 (4): 373-377.
  5. Gaspar M.M., Blanco D., Cruz M.E., Alonso M.J. Formulation of L-asparaginase load poly(lactide-to-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J. Control. Release. 1998, 52: 53-62.
  6. Goldberg A.I., Cooney D.A., Glynn J.P. et al. The effects of immunization to L-asparaginase on antitumor and enzymatic activity. Cancer Res. 1973, 33: 256-261.
  7. Jean-Frangois J., D'Urso E.M., Fortier G. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo. Biotechnol. Appl. Biochem. 1997, 26 (3): 203-212.
  8. Khan A., Hill J.M. Atopic hypersensitivity to L-asparaginase: resistance to immunosupression. Int. Arch. Allergy Appl. Immunol. 1971, 40 (3): 463-569.
  9. Kwon Y.M., Chung H.S., Moon C. et al. L-asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia. J. Control. Release. 2009, 139 (3): 182-189.
  10. Lazarus H., McCoy T.A., Farber S. et al. Nutritional requirements of human leukemnc cells. Asparagine requirements and the effect of L-asparaginase. Exp. Cell. Res. 1969, 57: 134-138.
  11. Moola Z.B., Scawen M.D., Atkinson T., Nicholls D.J. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes. Biochem. J. 1994, 302 (3): 921-927.
  12. Pokrovskaya MV, Aleksandrova S.S., Pokrovsky V.S., Omeljanjuk N.M., Borisova A.A., Anisimova N.Yu., Sokolov N.N. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase. Protein Expr. Purif. 2012, 82 (1): 150-154.
  13. Pokrovskaya M.V, Pokrovsky VS., Aleksandrova S.S., Anisimova N.Yu., Andrianov R.M., Treschalina E.M., Ponomarev G.V., Sokolov N.N. Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activty and antiproliferative effect. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2012, 6 (2): 123-131.
  14. Qian G., Zhou J., Wang D., He B. The chemical modification of E. coli L-asparaginase by N, O-carboxymethyl chitosan. Artif. Cell. Blood Substit. Immobil. Biotechnol. 1996, 24: 567-577.
  15. Warrell R.P. Jr., Arlin Z.A., Gee T.S. et al. Clincal evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. Cancer Treat. Rep. 1982, 66 (7): 1479-1485.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Dyakov I.N., Pokrovsky V.S., Sannikova E.P., Bulushova N.V., Pokrovskaya M.V., Aleksandrova S.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies